Skip to main content
IC
Takeda Pharmaceutical Company Limited (TKPHF)
OTCMKTS · Delayed Price · Currency is USD
27.94
-1.91 (-6.40%)
May 12, 2025, 3:52 PM EDT

TKPHF Revenue

In the fiscal year ending March 31, 2025, Takeda Pharmaceutical Company had annual revenue of 4.58T JPY with 7.45% growth. Takeda Pharmaceutical Company had revenue of 1.05T in the quarter ending March 31, 2025, with 0.24% growth.

Revenue
4,581.55B JPY
Revenue Growth
+7.45%
P/S Ratio
1.39
Revenue / Employee
92.97M JPY
Employees
49,281
Market Cap
42.50B USD

Revenue Chart

* This company reports financials in JPY.

History

Fiscal Year End Revenue Change Growth
Mar 31, 20254,581.55B317.79B7.45%
Mar 31, 20244,263.76B236.28B5.87%
Mar 31, 20234,027.48B458.47B12.85%
Mar 31, 20223,569.01B371.19B11.61%
Mar 31, 20213,197.81B-93.38B-2.84%
Mar 31, 2020 Pro Pro Pro
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro
Mar 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Endo Inc. 1.73B
Veradigm 588.02M
Tian'an Technology Group 1.78M
Glass House Brands 200.90M
Elite Pharmaceuticals 70.00M
Northwest Biotherapeutics 1.38M
BioStem Technologies 301.83M
American Oncology Network 1.76B
Revenue Rankings

Takeda Pharmaceutical Company News

More News